Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of RYGB on Alpha- and Beta Cell Function and Sensitivity to Incretins in Patients With Type 2 Diabetes

NCT04782999 is registered in ClinicalTrials.gov with Hvidovre University Hospital as lead sponsor.

NCT NCT04782999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04782999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of RYGB on Alpha- and Beta Cell Function and Sensitivity to Incretins in Patients With Type 2 Diabetes
Lead sponsor
Hvidovre University Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2015
Completion date
March 31, 2022
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, morbid, type2 diabetes